{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:08:35Z","timestamp":1791644915877,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.mycmed.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T22:31:29Z","timestamp":1414017089000},"page":"303-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents"],"prefix":"10.1016","volume":"24","author":[{"given":"F.","family":"Choukri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Benderdouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sednaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2014.05.001_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0732-8893(02)00440-6","article-title":"Antifungal susceptibility of South African oral yeast isolates from HIV\/AIDS patients and healthy individuals","volume":"44","author":"Blignaut","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1590\/S1806-83242011005000001","article-title":"In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals","volume":"25","author":"Brito","year":"2010","journal-title":"Braz Oral Res"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0020","first-page":"177","article-title":"Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J Muniz Infectious Diseases Hospital","volume":"21","author":"Buscemi","year":"2004","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/44.3.397","article-title":"In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole","volume":"44","author":"Carrillo-Munoz","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0030","first-page":"241","article-title":"Vaginal candidiasis: evolving trends in the incidence and treatment of non-Candida albicans infection","volume":"8","author":"Cauwenbergh","year":"1990","journal-title":"Curr Probl Obstet Gynecol Fertil"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0035","first-page":"61","article-title":"Vulvovaginal candidiasis","volume":"vol.5","author":"CDC","year":"2010"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0040","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A3","author":"Clinical Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/acm.2009.0281","article-title":"Antifungal activity of propolis extract against yeasts isolated from vaginal exudates","volume":"16","author":"Dalben-Dota","year":"2010","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000314022","article-title":"Management of recurrent vulvo-vaginal candidosis as a chronic illness","volume":"70","author":"Donders","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/neq029","article-title":"Antifungal activity of Brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis","author":"Dota","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0060","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMcp053720","article-title":"Clinical practice. Acute vulvovaginitis","volume":"355","author":"Eckert","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1447-0756.2008.00817.x","article-title":"Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006","volume":"34","author":"Fan","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C.\u00a0albicans","volume":"12","author":"Fidel","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/02681219480000341","article-title":"Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates","volume":"32","author":"Lynch","year":"1994","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1439-0507.2006.01284.x","article-title":"A 5-year (2000\u20132004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz Austria","volume":"49","author":"Paulitsch","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0095","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/clinids\/20.Supplement_1.S80","article-title":"Treatment options for vulvovaginal candidiasis, 1993","volume":"20","author":"Reef","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/CMR.14.4.643-658.2001","article-title":"Antifungal susceptibility testing: practical aspects and current challenges","volume":"14","author":"Rex","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010909504071","article-title":"Susceptibility profile of vaginal yeast isolates from Brazil","volume":"151","author":"Ribeiro","year":"2001","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0110","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1128\/JCM.43.5.2155-2162.2005","article-title":"Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases","volume":"43","author":"Richter","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1258\/ijsa.2011.011012","article-title":"European (IUSTI\/WHO) guideline on the management of vaginal discharge, 2011","volume":"22","author":"Sherrard","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJM199712253372607","article-title":"Vaginitis","volume":"337","author":"Sobel","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0125","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0002-9378(95)91490-0","article-title":"Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group","volume":"172","author":"Sobel","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/AAC.47.1.34-38.2003","article-title":"Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications","volume":"47","author":"Sobel","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0140","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa033114","article-title":"Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis","volume":"351","author":"Sobel","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9378(97)80026-9","article-title":"Prevalence of and risk factors for fungal vaginitis caused by non-albicans species","volume":"176","author":"Spinillo","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0150","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/JCM.02485-07","article-title":"Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection","volume":"46","author":"Vermitsky","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2014.05.001_bib0155","first-page":"85","article-title":"Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review","volume":"109","author":"Watson","year":"2002","journal-title":"BJOG"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523314001553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523314001553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:16:30Z","timestamp":1761110190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523314001553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1156523314001553"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2014.05.001","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}